Common Contracts
2 similar Supplemental Indenture contracts by Iqvia Holdings Inc.
SUPPLEMENTAL INDENTURE TO BE DELIVERED BY SUBSEQUENT GUARANTORSSupplemental Indenture • July 22nd, 2024 • Iqvia Holdings Inc. • Services-commercial physical & biological research • New York
Supplemental Indenture (this “Supplemental Indenture”), dated as of June 27, 2024, among Rules-Based Medicine Inc., a Delaware corporation, Lasso Marketing, Inc., a Delaware corporation and Cognitive Clinical Trials, LLC, a Delaware limited liability company (each a “Guaranteeing Subsidiary”), a subsidiary of IQVIA Inc., a Delaware corporation (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”) and as collateral agent (the “Collateral Agent”).
SUPPLEMENTAL INDENTURE TO BE DELIVERED BY SUBSEQUENT GUARANTORSSupplemental Indenture • July 22nd, 2024 • Iqvia Holdings Inc. • Services-commercial physical & biological research • New York
Supplemental Indenture (this “Supplemental Indenture”), dated as of June 27, 2024, among Rules-Based Medicine Inc., a Delaware corporation, Lasso Marketing, Inc., a Delaware corporation, and Cognitive Clinical Trials, LLC, a Delaware limited liability company (each a “Guaranteeing Subsidiary”), each a subsidiary of IQVIA Inc., a Delaware corporation (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”) and as collateral agent (the “Collateral Agent”).
